TechnoPhage, SA
  • About us
    • The company
    • Our track record
    • Quality Policy
  • Leadership
    • Board of Directors
    • Management Team
    • Scientific and Clinical Advisors
  • R&D
    • Product Pipeline
    • Therapeutic areas
  • GMP manufacturing
  • News Room
  • Contacts
Select Page

TechnoPhage ranked in the Deloitte Technology Fast 500 TM EMEA in 2012

31 Dez 2012 | News

Read here the ranking.

TechnoPhage small domain antibody TA101 featured in the press

20 Nov 2012 | News

TechnoPhage small domain antibody TA101 featured in the national press – Revista Visão Read here the program.

TechnoPhage invited to be present at the conference “Reindustrialização para o Crescimento e a Competitividade na Europa”

29 Out 2012 | News

TechnoPhage invited to be present at the conference “Reindustrialização para o Crescimento e a Competitividade na Europa” organized by the Portuguese Ministry of Economy and Employment. Read here the program.

TechnoPhage presentation at launching event of BIOBANCO – IMM

3 Out 2012 | News

Read here the program.

Collaborative manuscripts between TechnoPhage and the Faculty of Pharmacy of the University of Lisbon

29 Jun 2012 | News

Collaborative manuscripts between TechnoPhage and the Faculty of Pharmacy of the University of Lisbon on the characterization of lysins against Methicillin-Resistant Staphylococcus aures (MRSA) accepted for publication Read here the publication.
« Older Entries

Recent news

  • Technophage once again classified as ‘PME líder’ 6 de Janeiro, 2021

Search by year

2011 (1) 2012 (9) 2013 (7) 2014 (5) 2015 (11) 2016 (4) 2017 (4) 2018 (2) 2019 (7) 2020 (4) 2021 (1)

TechnoPhage SA

Av. Prof. Egas Moniz
Edifício Egas Moniz, Piso 2 – Ala A
1649-028 Lisboa, Portugal

T. +(351) 21 799 9472
F. +(351) 21 799 9459

General inquires:  info@technophage.pt
Human resources:  hr@technophage.pt
Data protection:  dataprotection@technophage.pt

TechnoPhage, 2020 – All Rights Reserved | Designed by Digitalloft

  • Follow
  • Follow